HopeStage
Back to all studies
RecruitingNCT07579481

Vortioxetine use in people with depression and migraine

About this titleRead the official source — NCT07579481
Observational studyAges 18+Italy
The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 28, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
31
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Interview / survey / observational
Locations
Italy
Age range
Over 18 Years
Official registry ID
NCT07579481
Official title
Show the full official title

Vortioxetine in the Treatment of Depression and Concomitant Migraine: an Explorative Study

Recruitment & locations

Currently recruiting

Rome

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Fondazione Policlinico Universitario Agostino Gemelli IRCCS.

Who can participate?

This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies